Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
This study has been completed.
Study NCT00401323. Last updated on March 24, 2009.
Information provided by Sanofi-Aventis
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Neoplasms
Neoplasm Recurrence, Local
Neoplasm Metastasis
Additional conditions recognized in this trial
Carcinoma, Squamous Cell
Neoplasms
Recurrence
More general conditions related to this trial
Carcinoma
Disease Attributes
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
docetaxel (XRP6976)
Additional drug interventions recognized in this trial
Docetaxel
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis
Back to top of Main Content